These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 12894520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E, Unfer R, Vahanian N, Link C.
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [Abstract] [Full Text] [Related]

  • 3. Rat sodium iodide symporter for radioiodide therapy of cancer.
    Mitrofanova E, Unfer R, Vahanian N, Daniels W, Roberson E, Seregina T, Seth P, Link C.
    Clin Cancer Res; 2004 Oct 15; 10(20):6969-76. PubMed ID: 15501976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM, Bergert ER, O'connor MK, Gendler SJ, Morris JC.
    Clin Cancer Res; 2005 Feb 15; 11(4):1483-9. PubMed ID: 15746050
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
    Carlin S, Cunningham SH, Boyd M, McCluskey AG, Mairs RJ.
    Cancer Gene Ther; 2000 Dec 15; 7(12):1529-36. PubMed ID: 11228531
    [Abstract] [Full Text] [Related]

  • 12. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
    Schipper ML, Weber A, Béhé M, Göke R, Joba W, Schmidt H, Bert T, Simon B, Arnold R, Heufelder AE, Behr TM.
    Cancer Res; 2003 Mar 15; 63(6):1333-8. PubMed ID: 12649195
    [Abstract] [Full Text] [Related]

  • 13. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
    Klutz K, Russ V, Willhauck MJ, Wunderlich N, Zach C, Gildehaus FJ, Göke B, Wagner E, Ogris M, Spitzweg C.
    Clin Cancer Res; 2009 Oct 01; 15(19):6079-86. PubMed ID: 19789324
    [Abstract] [Full Text] [Related]

  • 14. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV, Cengic N, Baker CH, Harrington KJ, Maletz K, Bergert ER, Vile R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2005 Feb 01; 12(3):272-80. PubMed ID: 15510175
    [Abstract] [Full Text] [Related]

  • 15. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
    Haberkorn U, Kinscherf R, Kissel M, Kübler W, Mahmut M, Sieger S, Eisenhut M, Peschke P, Altmann A.
    Gene Ther; 2003 May 01; 10(9):774-80. PubMed ID: 12704416
    [Abstract] [Full Text] [Related]

  • 16. Approaches to gene therapy with sodium/iodide symporter.
    Spitzweg C, Morris JC.
    Exp Clin Endocrinol Diabetes; 2001 May 01; 109(1):56-9. PubMed ID: 11573142
    [Abstract] [Full Text] [Related]

  • 17. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CY, Morris JC.
    Gene Ther; 2001 Oct 01; 8(20):1524-31. PubMed ID: 11704812
    [Abstract] [Full Text] [Related]

  • 18. Mitogen-activated protein kinase signaling enhances sodium iodide symporter function and efficacy of radioiodide therapy in nonthyroidal cancer cells.
    Jung KH, Paik JY, Ko BH, Lee KH.
    J Nucl Med; 2008 Dec 01; 49(12):1966-72. PubMed ID: 18997042
    [Abstract] [Full Text] [Related]

  • 19. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 01; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

  • 20. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
    Finocchiaro LM, Bumaschny VF, Karara AL, Fiszman GL, Casais CC, Glikin GC.
    Cancer Gene Ther; 2004 May 01; 11(5):333-45. PubMed ID: 15107812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.